Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT13387 alone or with abiraterone in castration-resistant prostate cancer no longer responding to abiraterone
2012-001574-28Phase 2Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of onalespib in prostate cancer (PCa) (2 arms), sponsored by Astex Pharmaceuticals. Primary endpoint: Primary endpoint Part A. Started May 2012; status: completed.
02
Drugs
onalespib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2012-001574-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001574-28.